Hongyan Mo
Southern Medical University
7 Papers
2 Citations
Hongyan Mo is an academic researcher from Southern Medical University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 4, co-authored 5 publications. Previous affiliations of Hongyan Mo include University of Pittsburgh.
Chat about Author
Papers
Klotho Ameliorates Kidney Injury and Fibrosis and Normalizes Blood Pressure by Targeting the Renin-Angiotensin System
Lili Zhou,Hongyan Mo,Jinhua Miao,Dong Zhou,Roderick J. Tan,Fan Fan Hou,Youhua Liu,Youhua Liu +7 more
TL;DR: Results demonstrate that Klotho exerts its renal protection by targeted inhibition of RAS, a pathogenic pathway known to play a key role in the evolution and progression of hypertension and chronic kidney disorders.
152
Fibroblast-Specific β-Catenin Signaling Dictates the Outcome of AKI.
Dong Zhou,Haiyan Fu,Liangxiang Xiao,Hongyan Mo,Hui Zhuo,Xiao-Jun Tian,Lin Lin,Jianhua Xing,Youhua Liu +8 more
TL;DR: It is suggested that fibroblast-specific β-catenin signaling can control tubular injury and repair in AKI by modulating HGF expression.
60
High Fat Diet Induces Kidney Injury via Stimulating Wnt/β-Catenin Signaling
Ying Yu,Hongyan Mo,Hui Zhuo,Chen-hui Yu,Youhua Liu +4 more
TL;DR: Intervention with ICG-001, a small molecule Wnt/β-catenin inhibitor, improved renal function, inhibited proinflammatory cytokines expression, reduced proteinuria and alleviated podocyte injury in palmitate-treated podocytes, suggesting that Wnt /β-Catenin signaling is involved in the pathogenesis of high-fat diet-induced kidney injury.
Sonic hedgehog selectively promotes lymphangiogenesis after kidney injury through noncanonical pathway
TL;DR: It is suggested that tubule-derived sonic hedgehog (Shh) ligand is a novel lymphangiogenic factor that plays a crucial role in mediating lymphatic endothelial cell proliferation and expansion after kidney injury and is identified as a novel mitogen that selectively promotes lymphatic, but not vascular, endothelium cell proliferation.